A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice

Alcohol use disorder (AUD) affects over 18 million people in the US. Unfortunately, pharmacotherapies available for AUD have limited clinical success and are under prescribed. Previously, we established that avermectin compounds (ivermectin [IVM] and moxidectin) reduce alcohol (ethanol/EtOH) consump...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Joshua, Carry, Eileen, Xue, Chen, Zhang, Jifeng, Liang, Jing, Roberge, Jacques Y., Davies, Daryl L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004700/
https://www.ncbi.nlm.nih.gov/pubmed/33810134
http://dx.doi.org/10.3390/molecules26061791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004700/
https://www.ncbi.nlm.nih.gov/pubmed/33810134
http://dx.doi.org/10.3390/molecules26061791

Ejemplares similares